Skip to results
Modify your search
NARROW
1-11 of 11
Authors: Brian L. Claggett
Sort by
Journal Article
Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trial
Alexander Peikert and others
European Heart Journal, ehaf057, https://doi.org/10.1093/eurheartj/ehaf057
Published: 28 January 2025
Journal Article
Sodium-glucose co-transporter 2 inhibitors and new-onset diabetes in cardiovascular or kidney disease
John W Ostrominski and others
European Heart Journal, Volume 46, Issue 14, 7 April 2025, Pages 1321–1331, https://doi.org/10.1093/eurheartj/ehae780
Published: 21 November 2024
Journal Article
Cardiac biomarkers and effects of aficamten in obstructive hypertrophic cardiomyopathy: the SEQUOIA-HCM trial
Caroline J Coats and others
European Heart Journal, Volume 45, Issue 42, 7 November 2024, Pages 4464–4478, https://doi.org/10.1093/eurheartj/ehae590
Published: 01 September 2024
Journal Article
EDITOR'S CHOICE
Electronic nudges increase influenza vaccination utilization after myocardial infarction: the nationwide NUDGE-FLU implementation trial
Ankeet S Bhatt and others
European Heart Journal, Volume 45, Issue 20, 21 May 2024, Pages 1856–1858, https://doi.org/10.1093/eurheartj/ehae235
Published: 10 April 2024
Journal Article
Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER
Jawad H Butt and others
European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2170–2183, https://doi.org/10.1093/eurheartj/ehad276
Published: 23 May 2023
Journal Article
Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF
Muthiah Vaduganathan and others
European Heart Journal, Volume 44, Issue 31, 14 August 2023, Pages 2982–2993, https://doi.org/10.1093/eurheartj/ehad344
Published: 21 May 2023
Journal Article
Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial
Marco Metra and others
European Heart Journal, Volume 43, Issue 48, 21 December 2022, Pages 5006–5016, https://doi.org/10.1093/eurheartj/ehac293
Published: 22 May 2022
Journal Article
EDITOR'S CHOICE
Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial
Scott D Solomon and others
European Heart Journal, Volume 43, Issue 23, 14 June 2022, Pages 2212–2220, https://doi.org/10.1093/eurheartj/ehac144
Published: 23 March 2022
Journal Article
EDITOR'S CHOICE
A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fraction
Muthiah Vaduganathan and others
European Heart Journal, Volume 41, Issue 25, 1 July 2020, Pages 2356–2362, https://doi.org/10.1093/eurheartj/ehaa184
Published: 28 March 2020
Journal Article
EDITOR'S CHOICE
Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials
Azmil H. Abdul-Rahim and others
European Heart Journal, Volume 38, Issue 10, 7 March 2017, Pages 742–750, https://doi.org/10.1093/eurheartj/ehw509
Published: 13 November 2016
Journal Article
Mortality following a cardiovascular or renal event in patients with type 2 diabetes in the ALTITUDE trial
Get access
Pardeep S. Jhund and others
European Heart Journal, Volume 36, Issue 36, 21 September 2015, Pages 2463–2469, https://doi.org/10.1093/eurheartj/ehv295
Published: 18 July 2015
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals